Wuhan General Group (China), Inc.Wuhan General Group (China), Inc.Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc.

No trades
See on Supercharts

WUHN fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
WUHN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company